Design Therapeutics Inc. (DSGN)
5.01
-0.05 (-0.99%)
At close: Jan 28, 2025, 2:31 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -2.22 | -9.75 | -27.68 | -136.25 | -551.11 |
| PS Ratio | n/a | n/a | n/a | 4.99M | 1.35M |
| PB Ratio | 0.53 | 1.75 | 2.57 | -99.7 | -309.75 |
| P/FCF Ratio | -2.52 | -10.94 | -31.82 | -129 | -8.12K |
| P/OCF Ratio | -2.53 | -11.14 | -33.48 | -130.13 | -8.12K |
| OCF/S Ratio | n/a | n/a | n/a | -38.36K | -166.67 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | n/a | -0.19 |
| Quick Ratio | 29.58 | 31.20 | 72.72 | 15.50 | 0.02 |
| Current Ratio | 29.58 | 31.10 | 72.96 | 15.55 | 0.02 |
| Asset Turnover | n/a | n/a | n/a | 0.00 | 0.01 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.24 | -0.18 | -0.09 | 0.73 | 0.56 |
| Return on Assets (ROA) | -0.23 | -0.17 | -0.09 | -0.23 | -22.74 |
| Return on Capital (ROIC) | -0.28 | -0.2 | -0.09 | -0.24 | 0.52 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | -2.11K% | -98.32% |
| Net Profit Margin | n/a | n/a | n/a | -3.66M% | -245.44K% |
| Pretax Profit Margin | n/a | n/a | n/a | -3.66M% | -245.44K% |
| Operating Profit Margin | n/a | n/a | n/a | -3.69M% | -228.78K% |
| FCF Margin | n/a | n/a | n/a | -3.87M% | -16.67K% |
| EBITDA Margin | n/a | n/a | n/a | -3.68M% | -16.67K% |